IntraOp Announces First Randomized Phase II Selection Trial of FLASH Versus Conventional Radiotherapy for Patients with Localized Carcinomas
SUNNYVALE, Calif.--(BUSINESS WIRE)--IntraOp Medical Corporation announced the world's first Phase II Electron FLASH Trial. It marks the first time a randomized trial will compare FLASH radiotherapy* to conventional radiotherapy in treating nonmelanoma skin cancer (NMSC). It is the second clinical human trial to use the IntraOp® Mobetron® electron-based linear accelerator...
